OtherNeuropharmacology
The dopamine stabilizers (-)-OSU6162 and ACR16 show high in vivo D2 receptor occupancy, antipsychotic- like efficacy and low potential for motor side effects in the rat
Sridhar Natesan, Kjell A. Svensson, Greg E. Reckless, Jose N. Nobrega, Karen B.L. Barlow, Anette M. Johansson and Shitij Kapur
Journal of Pharmacology and Experimental Therapeutics April 28, 2006, DOI: https://doi.org/10.1124/jpet.106.102905
Sridhar Natesan
Kjell A. Svensson
Greg E. Reckless
Jose N. Nobrega
Karen B.L. Barlow
Anette M. Johansson
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherNeuropharmacology
The dopamine stabilizers (-)-OSU6162 and ACR16 show high in vivo D2 receptor occupancy, antipsychotic- like efficacy and low potential for motor side effects in the rat
Sridhar Natesan, Kjell A. Svensson, Greg E. Reckless, Jose N. Nobrega, Karen B.L. Barlow, Anette M. Johansson and Shitij Kapur
Journal of Pharmacology and Experimental Therapeutics April 28, 2006, DOI: https://doi.org/10.1124/jpet.106.102905
OtherNeuropharmacology
The dopamine stabilizers (-)-OSU6162 and ACR16 show high in vivo D2 receptor occupancy, antipsychotic- like efficacy and low potential for motor side effects in the rat
Sridhar Natesan, Kjell A. Svensson, Greg E. Reckless, Jose N. Nobrega, Karen B.L. Barlow, Anette M. Johansson and Shitij Kapur
Journal of Pharmacology and Experimental Therapeutics April 28, 2006, DOI: https://doi.org/10.1124/jpet.106.102905
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement